EUVIMEDEUVIMED entdecken
Crossref

LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease

Z Gan-Or, A Bar-Shira, A Mirelman, T Gurevich, M Kedmi, N Giladi, A Orr-Urtreger

neurogenetics · 2010-02 · 11 (1) · 121-125

DOI: 10.1007/s10048-009-0198-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift neurogenetics, online erschienen am 21.05.2009. Verfasst von Z Gan-Or und 6 weiteren Autor:innen. Beteiligte Einrichtung: Genetic Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 64239, Israel. Hauptthemen laut MEDLINE: Gene Expression Regulation, Mutation. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GBA and LRRK2 mutations increase susceptibility to Parkinson disease (PD), which is characterized by various disabling symptoms. An extended cohort of 600 Ashkenazi PD patients was screened for the LRRK2 G2019S and for eight GBA mutations. Reported initial symptoms were compared between three genotypic groups of patients: carriers of GBA mutations, carriers of LRRK2 G2019S mutation, and non-carriers. More LRRK2 G2019S carriers reported muscle stiffness (rigidity, p = 0.007) and balance disturbances (p = 0.008), while more GBA mutation carriers reported slowness (bradykinesia, p = 0.021). These results suggest distinct effects of LRRK2 or GBA mutations on the initial symptoms of PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gene Expression RegulationMutationAdultAgedAged, 80 and overCohort StudiesFemaleGenetic Predisposition to DiseaseGlucosylceramidaseHumansLeucine-Rich Repeat Serine-Threonine Protein Kinase-2MaleMiddle AgedParkinson DiseasePhenotypeProtein Serine-Threonine Kinases

Substanzen

LRRK2 protein, humanLeucine-Rich Repeat Serine-Threonine Protein Kinase-2Protein Serine-Threonine KinasesGlucosylceramidase

Autor:innen und Institutionen

  • Genetic Institute, Tel Aviv Sourasky Medical Center, 6 Weizmann Street, Tel Aviv, 64239, Israel.

Zitieren

APA

Gan-Or, Z., Bar-Shira, A., Mirelman, A., Gurevich, T., Kedmi, M., Giladi, N., & Orr-Urtreger, A. (2010). LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. neurogenetics, 11(1), 121-125. https://doi.org/10.1007/s10048-009-0198-9

Vancouver

Gan-Or Z, Bar-Shira A, Mirelman A, Gurevich T, Kedmi M, Giladi N, et al. LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease. neurogenetics. 2010;11(1):121-125. doi:10.1007/s10048-009-0198-9

BibTeX
@article{GanOr2010,
  author = {Gan-Or, Z and Bar-Shira, A and Mirelman, A and Gurevich, T and Kedmi, M and Giladi, N and Orr-Urtreger, A},
  title = {LRRK2 and GBA mutations differentially affect the initial presentation of Parkinson disease},
  journal = {neurogenetics},
  year = {2010},
  volume = {11},
  number = {1},
  pages = {121--125},
  doi = {10.1007/s10048-009-0198-9}
}
Kostenlos starten →